Clinical trial
A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
NCT03098732 is registered in ClinicalTrials.gov with Pulse Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
- Lead sponsor
- Pulse Therapeutics
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- March 22, 2017
- Completion date
- December 31, 2020
- Enrollment
- 120 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cerebrovascular disorders, infarction, middle cerebral artery, intracranial embolism and thrombosis, neurologic disorder, stroke, acute, stroke, ischemic, strokes thrombotic